Erectile Function Clinical Trial
Official title:
FirmTech User Research Trial
NCT number | NCT05853822 |
Other study ID # | Firmtech_RMANJ_01 |
Secondary ID | |
Status | Recruiting |
Phase | |
First received | |
Last updated | |
Start date | May 2, 2023 |
Est. completion date | June 2024 |
The objective of this study is to see whether a home-use penile constriction device, Firmtech Tech Ring, can be determined to be superior to the Giddy device through evaluation of Leikert scale scores to assess ease of use and participant comfort and satisfaction with erectile quality with these devices. The primary outcome will be the satisfaction with use of the device as assessed through the Leikert scores. The other outcomes will be secondary.
Status | Recruiting |
Enrollment | 75 |
Est. completion date | June 2024 |
Est. primary completion date | May 2024 |
Accepts healthy volunteers | |
Gender | Male |
Age group | 18 Years to 70 Years |
Eligibility | Inclusion Criteria: - All English-speaking participants > 18 years old recruited through social media. - Physically and emotionally capable of engaging in sexual activity with at least one attempt per week of masturbation or sexual intercourse Exclusion Criteria: - Men who cannot understand English. - Men with a prior or current penile implant. - Transgender or non-binary individuals - Men diagnosed with a hidden or buried penis. - Investigator's impression of expected poor participant compliance or anatomic inadequacy (penile size/girth) - Any psychiatric disorder, which, in the opinion of the investigator, would prohibit participation. - Coagulopathy or other blood disorder which the investigator determines would affect the participant's participation in the trial. - Any tumor in the pelvic or penile region within the last 3 years - Men with an active caregiver who are unable to live independently. - Men who the provider is concerned would be at high risk for non-healing wounds of the penis. - Participants with sensory disorders like sensory processing disorder, sensory integration dysfunction disorder, neuropathies, etc. |
Country | Name | City | State |
---|---|---|---|
United States | IVI RMA New Jersey | Basking Ridge | New Jersey |
Lead Sponsor | Collaborator |
---|---|
Reproductive Medicine Associates of New Jersey | FirmTech, Inc. |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Device satisfaction via Leikert scores | A survey will be completed for each device after utilization | 2 weeks after receiving device |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03790995 -
Functional Outcomes and QoL in Patients With High Versus Low and Intermediate Risk Prostate Cancer Treated by RARP
|
||
Completed |
NCT03389867 -
Open Label Study to Evaluate the Effect of Kaempferia Parviflora in Support of Erectile Function and Male Sexual Health
|
N/A | |
Suspended |
NCT03143790 -
Ekstracorporal Shock Wave Therapy as a Treatment for Erectile Dysfunction in Men After Prostatectomy
|
N/A |